Ralph A. DeFronzo



Ralph A. DeFronzo, MD, is Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Deputy Director of the Texas Diabetes Institute, San Antonio, Texas.  Dr. DeFronzo is a graduate of Yale University (BS) and Harvard Medical School (MD) and did his training in Internal Medicine at the Johns Hopkins Hospital.  He completed fellowships in Endocrinology at the NIH and Baltimore City Hospitals and in Nephrology at the Hospital of the University of Pennsylvania.  Subsequently, he joined the faculty at the Yale University School of Medicine (1975-88) as an Assistant/Associate Professor.  From 1988 to present Dr. DeFronzo has been Professor of Medicine and Chief of the Diabetes Division at University of Texas Health Science Center at San Antonio.  He also serves as the Deputy Director of the Texas Diabetes Institute.

His major interests focus on the pathogenesis and treatment of type 2 diabetes mellitus and the central role of insulin resistance in the metabolic-cardiovascular cluster of disorders known collectively as the Insulin Resistance Syndrome. 

Dr. DeFronzo is the recipient of the ADA’s Albert Renold Award (2002) for lifetime commitment to the training of young diabetes investigators.  Dr. DeFronzo received the Banting Award from the ADA (2008) and the Claude Bernard Award from the EASD (2008).  These represent the highest scientific achievement awards given by the American and European Diabetes Associations, respectively.  With more than 650 articles published in peer-reviewed medical journals, Dr. DeFronzo is a distinguished clinician, teacher, and investigator.